189 related articles for article (PubMed ID: 17986517)
1. Evaluation of an electronic critical drug interaction program coupled with active pharmacist intervention.
Humphries TL; Carroll N; Chester EA; Magid D; Rocho B
Ann Pharmacother; 2007 Dec; 41(12):1979-85. PubMed ID: 17986517
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
[TBL] [Abstract][Full Text] [Related]
3. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation.
Smith DH; Perrin N; Feldstein A; Yang X; Kuang D; Simon SR; Sittig DF; Platt R; Soumerai SB
Arch Intern Med; 2006 May; 166(10):1098-104. PubMed ID: 16717172
[TBL] [Abstract][Full Text] [Related]
4. Management of drug-interaction alerts in community pharmacies.
Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
[TBL] [Abstract][Full Text] [Related]
5. Reducing warfarin medication interactions: an interrupted time series evaluation.
Feldstein AC; Smith DH; Perrin N; Yang X; Simon SR; Krall M; Sittig DF; Ditmer D; Platt R; Soumerai SB
Arch Intern Med; 2006 May; 166(9):1009-15. PubMed ID: 16682575
[TBL] [Abstract][Full Text] [Related]
6. Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies.
Buurma H; Schalekamp T; Egberts AC; De Smet PA
Ann Pharmacother; 2007 Dec; 41(12):2024-31. PubMed ID: 17971404
[TBL] [Abstract][Full Text] [Related]
7. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
Halkin H; Katzir I; Kurman I; Jan J; Malkin BB
Clin Pharmacol Ther; 2001 Apr; 69(4):260-5. PubMed ID: 11309555
[TBL] [Abstract][Full Text] [Related]
8. Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people.
Simon SR; Smith DH; Feldstein AC; Perrin N; Yang X; Zhou Y; Platt R; Soumerai SB
J Am Geriatr Soc; 2006 Jun; 54(6):963-8. PubMed ID: 16776793
[TBL] [Abstract][Full Text] [Related]
9. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.
Becker ML; Caspers PW; Kallewaard M; Bruinink RJ; Kylstra NB; Heisterkamp S; de Valk V; van der Veen AA; Stricker BH
Pharm World Sci; 2007 Apr; 29(2):51-7. PubMed ID: 17187223
[TBL] [Abstract][Full Text] [Related]
10. Assessing the value of electronic prescribing in ambulatory care: a focus group study.
Weingart SN; Massagli M; Cyrulik A; Isaac T; Morway L; Sands DZ; Weissman JS
Int J Med Inform; 2009 Sep; 78(9):571-8. PubMed ID: 19395307
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility.
Delate T; Chester EA; Stubbings TW; Barnes CA
Pharmacotherapy; 2008 Apr; 28(4):444-52. PubMed ID: 18363528
[TBL] [Abstract][Full Text] [Related]
12. Pharmacy-based computer system for monitoring and reporting drug interactions.
Haumschild MJ; Ward ES; Bishop JM; Haumschild MS
Am J Hosp Pharm; 1987 Feb; 44(2):345-8. PubMed ID: 3565394
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial to improve prescribing safety in ambulatory elderly patients.
Raebel MA; Charles J; Dugan J; Carroll NM; Korner EJ; Brand DW; Magid DJ
J Am Geriatr Soc; 2007 Jul; 55(7):977-85. PubMed ID: 17608868
[TBL] [Abstract][Full Text] [Related]
14. Survey of drug-related problems identified by community pharmacies.
Hämmerlein A; Griese N; Schulz M
Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients.
Raebel MA; Chester EA; Newsom EE; Lyons EE; Kelleher JA; Long C; Miller C; Magid DJ
Pharmacotherapy; 2006 May; 26(5):619-26. PubMed ID: 16637791
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.
Grabe DW; Low CL; Bailie GR; Eisele G
Clin Nephrol; 1997 Feb; 47(2):117-21. PubMed ID: 9049460
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.
de Maat MM; de Boer A; Koks CH; Mulder JW; Meenhorst PL; van Gorp EC; Mairuhu AT; Huitema AD; Beijnen JH
J Clin Pharm Ther; 2004 Apr; 29(2):121-30. PubMed ID: 15068400
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
19. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial.
Schnipper JL; Hamann C; Ndumele CD; Liang CL; Carty MG; Karson AS; Bhan I; Coley CM; Poon E; Turchin A; Labonville SA; Diedrichsen EK; Lipsitz S; Broverman CA; McCarthy P; Gandhi TK
Arch Intern Med; 2009 Apr; 169(8):771-80. PubMed ID: 19398689
[TBL] [Abstract][Full Text] [Related]
20. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions.
Bond C; Matheson C; Williams S; Williams P; Donnan P
Br J Gen Pract; 2000 Apr; 50(453):271-5. PubMed ID: 10897509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
